Log In
BCIQ
Print this Print this
 

TB 101

  Manage Alerts
Collapse Summary General Information
Company Triskel Biopharmaceuticals AG
DescriptionRecombinant-human enzyme
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard Indication Pulmonary (unspecified)
Indication DetailsPrevent and reduce long-term chronic respiratory morbidity (CRM) in prematurely born babies
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today